Jefferies analyst Glen Santangelo lowered the firm’s price target on Viatris (VTRS) to $13 from $15 and keeps a Buy rating on the shares after updating the firm’s for Q4 results and 2025 guidance. While fundamentals continue to improve, with 3% organic growth expected in FY25, the company’s negative headline EBITDA guidance has “overshadowed” improving operational performance, the analyst tells investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VTRS: